PreTel Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $352K

  • Investors
  • 6

PreTel General Information

Description

Developer of uterine electromyography monitoring sensors designed to examine all stages of pregnancy. The company's sensors identify independent contraction activity of individual regions of the uterus and permit improved care in the preterm labor patient, managing the progress of labor at the time of delivery and safety to the admiration of induction therapy, enabling hospitals to improve both maternal and neonatal outcomes in the labor and delivery department and avoid unnecessary C-Section deliveries, post-delivery maternal hemorrhage, and expensive neonatal intensive care nursery stays.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 871 McCallie Avenue
  • Chattanooga, TN 37403
  • United States
+1 (423) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PreTel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2019 $352K 00.000 Completed Generating Revenue
4. Early Stage VC 27-Dec-2017 00000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 15-Mar-2017 00.00 00.000 00.00 Completed Generating Revenue
2. Seed Round 08-Jan-2016 $375K $450K 00000 Completed Generating Revenue
1. Seed Round 30-Mar-2015 $74.9K $74.9K 00000 Completed Startup
To view PreTel’s complete valuation and funding history, request access »

PreTel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 2 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 115,300 $0.000100 5% $0.65 $0.65 1x $0.65 6.43%
To view PreTel’s complete cap table history, request access »

PreTel Patents

PreTel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190380642-A1 Electromyography based drug delivery Pending 25-Jan-2017 0000000000
EP-3573524-A1 Electromyography based drug delivery Pending 25-Jan-2017 0000000000
EP-3573524-A4 Electromyography based drug delivery Pending 25-Jan-2017 0000000000 0
EP-3541280-A4 Vaginal electrode Inactive 15-Nov-2016 0000000000
US-20200178879-A1 Vaginal electrode Pending 15-Nov-2016 A61B5/4337
To view PreTel’s complete patent history, request access »

PreTel Executive Team (3)

Name Title Board Seat Contact Info
Marc Finch Co-Founder & Chief Executive Officer
Roger Young MD Co-Founder, Chief Medical Officer & President
Mark Samuels Executive Chairman
To view PreTel’s complete executive team members history, request access »

PreTel Board Members (4)

Name Representing Role Since
Blake Patton Tech Square Ventures Board Member 000 0000
David Adair MD Self Board Member 000 0000
Gregg Raybuck PreTel Board Member 000 0000
Mark Samuels Self Executive Chairman 000 0000
To view PreTel’s complete board members history, request access »

PreTel Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Charleston Angel Partners Angel Group Minority 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0
Foley Ventures Venture Capital Minority 000 0000 000000 0
Tech Square Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »